Brief: Novartis to spend extra $200 mln to push Entresto - CEO

Roche Holding AG

19/07/2016 06:36

July 19 (Reuters) - Novartis CEO says on call with 
journalists: 
    * Novartis ceo says expects Alcon to return to growth this 
year 
    * Novartis says anticipates more difficult u.s. Pricing 
environment 
    * Novartis ceo says planning for u.s. Environment without 
price increases 
    * Novartis ceo says expects EMA drugs approval agency to 
leave london after brexit vote 
    * Novartis ceo says entresto to be strong in u.s. And europe 
markets 
    * Novartis ceo says brexit vote has no impact on our 
willingness to invest in britain 
    * Novartis ceo says to spend additional $200 million on 
entresto push in h2 
    * Novartis ceo says sees cosentyx peak sales likely over $4 
billion 
    * Novartis ceo says don't see big impact on industry from 
Brexit 
    * Novartis says no change on Roche stake, will look to exit 
if opportunity exists 
    * Extra Entresto spending could cost 1-2 percent of core 
operating income 
 
Source text for Eikon:  ID:  
Further company coverage:  urn:newsml:reuters.com:*:nL8N1A50I8 
 
 (Reporting By Zurich newsroom) 
 ((zurich.newsroom@thomsonreuters.com; +41 58 306 7336;))